这株细胞建于1994年三月。这株肺腺癌在EGFR酪氨酸激酶区域有一个获得性突变(E746-A750缺失)。 患者在25岁到26岁时每个月抽1包烟。 在诊断前12年不再抽烟。
所供Luciferase 稳转细胞株采用慢病毒法构建,除稳定高效地表达 luciferase 基因外,还具有特异性强、成像质量高、发光强度可精确定量等优点,可实现包括启动子活性研究、哺乳动物细胞双杂交实验以及活体动物成像实验等多方面的灵活应用。
基因报告系统广泛应用于真核生物基因表达和细胞生理学的研究,是提高实验准确度的常用方法。荧光素酶(Luciferase)是以荧光素(luciferin)或脂肪醛(firefly aldehyde)为底物来检测荧光素酶活性的一种常见基因报告系统,因其具有方便快捷、灵敏度强、成功率高等优点,在基因表达的研究中得到广泛应用。
细胞名称:荧光素酶标记的人非小细胞肺癌细胞
细胞简称:HCC827-Luc
产品货号:TCH-C182L
转染方法:慢病毒
抗性:Puro
靶细胞名称:HCC827
靶细胞别名:HCC-827; HCC 827; HCC0827; Hamon Cancer Center 827
种属来源:人
组织来源:肺
疾病特征:肺腺癌
细胞形态:上皮细胞样
生长特性:贴壁生长
培养体系:RPMI-1640+10% FBS+2.0 ug/mL Puromycin+1% P/S
配套培养基货号:TCH-G182L
传代比例:1:3-1:4,每2-3天换液一次
传代周期:24-48 h
培养条件:气相:95%空气+5%CO2,温度:37℃
冻存条件:60%基础培养基+30%FBS+10%DMSO,液氮储存
质量检测:细菌、真菌、支原体检测均为阴性
参考文献:Girard L , et al. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60: 4894-4906, 2000. PubMed: 10987304 Burbee DG , et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93: 691-699, 2001. PubMed: 11333291 Toyooka S , et al. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Clin. Cancer Res. 8: PubMed: 12114433 Virmani A , et al. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Int. J. Cancer 107: 341-345, 2003. PubMed: 14506731 Liu CX , et al. LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines. Cancer Res. 60: 1961-1967, 2000. PubMed: 10766186 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Centers for Disease Control (1993), Biosafety in Microbiological and Biomedical Laboratories Human Health Service Publication No. (CDC) 93-8395. U.S. Dept. of Health and Human Services; 3rd Edition U.S. Government Printing Office Washington D.C.
收货当天如何处理细胞?
收到细胞后请务必仔细阅读产品资料,了解细胞相关信息,如贴壁特性 (贴壁/悬浮/半贴壁半悬浮)、细胞形态、培养体系、传代比例和换液频率等。